Manhattan Scients Company Insiders

Manhattan Scients Management Team Effectiveness

The company has return on total asset (ROA) of (0.1724) % which means that it has lost $0.1724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.5111) %, meaning that it created substantial loss on money invested by shareholders. Manhattan Scients' management efficiency ratios could be used to measure how well Manhattan Scients manages its routine affairs as well as how well it operates its assets and liabilities. Manhattan Scients maintains a total of 559.28 Million outstanding shares. Manhattan Scients secures 18.63 % of its outstanding shares held by insiders and 0.3 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in pink sheets such as Manhattan Scients in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Manhattan Scients, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Manhattan Scients Workforce Comparison

Manhattan Scients Benchmark Summation

Manhattan Scients Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Manhattan Scients often depends on how effective the management is. Manhattan Scients management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Manhattan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Manhattan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Manhattan Scients' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Manhattan Scients. Check Manhattan Scients' Beneish M Score to see the likelihood of Manhattan Scients' management manipulating its earnings.

When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.